LexDanaLexDanabeta
Inventor

Xiaoxia Liu

Inventor
Lake Forest, CA, US

Overview

36→
Patents
2004–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 36 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds26%
C07CAcyclic or carbocyclic compounds15%
A61KPreparations for medical, dental or toiletry purposes12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
A61CDentistry2%
A61BDiagnosis1%
G06FElectric digital data processing1%
H01LSemiconductor devices1%
H04LTransmission of digital information, e.g. telegraphic communication1%
PatentTitleYear
10,869,396Motherboard to be cut202010,287,243Sulfur derivatives as chemokine receptor modulators201910,064,698Dental drill head201810,058,398Turbine dental drill mechanism and turbine head with same mounted therein20189,670,190'Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators'20179,663,460'Sulfur derivatives as chemokine receptor modulators'20179,603,834'1,2- bis-sulfonamide derivatives as chemokine receptor modulators'20179,550,746'Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators'20179,416,120'Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators'20169,371,278'Sulfur derivatives as chemokine receptor modulators'20169,328,067'Sulfur derivatives as chemokine receptor modulators'20169,021,593'XSS detection method and device'20158,927,544'Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators'20158,877,804'Sulfur derivatives as chemokine receptor modulators'20148,822,530'Sulfur derivatives as chemokine receptor modulators'20148,815,915'Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators'20148,791,161'Sulfur derivatives as chemokine receptor modulators'20148,729,066'1,2- bis-sulfonamide derivatives as chemokine receptor modulators'20148,580,779'1,2-bis-sulfonamide derivatives as chemokine receptor modulators'20138,524,917'6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity'20138,524,745'Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators'20138,518,913'Phosphorous derivatives as chemokine receptor modulators'20138,513,220'Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity'20138,450,367'Sulfur derivatives as chemokine receptor modulators'20137,737,173'Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity'20107,728,014'Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity'20107,638,648'Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same'20097,476,673'Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors'20097,468,391'Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B'20087,432,388'Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity'20087,351,737'4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity'20087,253,319'Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity'20077,226,951'Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same'20076,887,896'7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity'20056,740,676'4-(8-ETHYNYL, 8-VINYL OR 8-ETHYNYL-METHYL)-6-CHROMANOYL-BENZOIC AND 2-4-(8-ETHYNYL, 8-VINYL OR 8-ETHYNYL-METHYL)-6-CHROMANOYL-PHENYL-ACETIC ACID, THEIR ESTERS AND SALTS HAVING CYTOCHROME P450RAI INHIBITORY ACTIVITY'20046,683,092'3-(C5-14ALKYL-2-OXO-1,2,3,4-TETRAHYDRO-QUINOLIN-6-YL)-3-OXO-PROPENYL-PHENYL AND 3-(C5-14ALKYL-2-OXO-1,2,3,4- TETRAHYDRO-QUINOLIN-6-YL)-3-OXO-PROPENYL-HETEROARYL DERIVATIVES HAVING ANTI-TUMOR ACTIVITY'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2019Patents assigned to ALLERGAN INC (32)· patent assignee history
2004–2009Based in Tustin, CA, US· patent location history
2009–2019Based in Lake Forest, CA, US· patent location history
2013–2015Patents assigned to LIU XIAOXIA (6)· patent assignee history
2013Patents assigned to DONELLO JOHN E (4)· patent assignee history
2013Patents assigned to YUAN HAIQING (4)· patent assignee history
2013Patents assigned to BEARD RICHARD I (3)· patent assignee history
2014–2017Based in Irvine, CA, US· patent location history
2015–2020Based in Beijing, CN· patent location history
2018Based in Henan, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ALLERGAN INC322004–2019
LIU XIAOXIAself62013–2015
DONELLO JOHN E42013
YUAN HAIQING42013
BEARD RICHARD I32013
Locations
LocationPatentsSpan
Lake Forest, California, US212009–2019
Tustin, California, US82004–2009
Beijing, CN22015–2020
Irvine, California, US22014–2017
Henan, CN12018